Send the following on WhatsApp
Continue to ChatImmunologic Efficacy of E39 & E39’ Vaccination in a Phase I/IIa Trial in Ovarian & Endometrial Cancer Patients https://www.sages.org/video/immunologic-efficacy-of-e39-e39-vaccination-in-a-phase-i-iia-trial-in-ovarian-endometrial-cancer-patients/